Share Price and Basic Stock Data
Last Updated: February 6, 2026, 2:17 pm
| PEG Ratio | 3.62 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Fine Organic Industries Ltd operates in the organic chemicals sector, focusing on specialty chemicals. The company reported a robust sales figure of ₹3,023 Cr for the year ending March 2023, a significant increase from ₹1,876 Cr in March 2022. However, sales declined to ₹2,123 Cr in March 2024, followed by a slight recovery to ₹2,269 Cr in March 2025. The trailing twelve months (TTM) sales stood at ₹2,309 Cr, indicating a stable revenue trajectory despite recent fluctuations. Quarterly sales figures also reflect variability, peaking at ₹919 Cr in September 2022 but tapering to ₹540 Cr in September 2023. The company’s ability to generate consistent revenue growth remains crucial, particularly in a competitive landscape where market dynamics can shift rapidly.
Profitability and Efficiency Metrics
Fine Organic’s profitability indicators present a mixed picture, with a reported net profit of ₹405 Cr for the year ending March 2025, down from ₹618 Cr in March 2023. The operating profit margin (OPM) recorded a decline, standing at 23% for March 2025 compared to a higher 27% in March 2023. The company’s return on equity (ROE) was 19.5%, while the return on capital employed (ROCE) was 26.4%, both reflecting strong operational efficiency relative to industry standards. The interest coverage ratio (ICR) was notably high at 278.05x, indicating exceptional ability to meet interest obligations. However, the cash conversion cycle (CCC) extended to 110 days, suggesting potential inefficiencies in working capital management that could impact liquidity.
Balance Sheet Strength and Financial Ratios
Fine Organic’s balance sheet demonstrates considerable strength, with total reserves rising to ₹2,462 Cr as of September 2025, reflecting a solid equity base. The company’s borrowings were minimal at ₹16 Cr, resulting in a total debt-to-equity ratio of 0.00, indicating a debt-free status that enhances financial stability. The price-to-book value ratio stood at 5.34x, suggesting a premium valuation compared to book value, which was ₹748.61 per share as of March 2025. The current ratio at 8.46x and quick ratio at 6.76x highlight strong liquidity, allowing the company to cover short-term liabilities comfortably. However, the enterprise value (EV) to net operating revenue ratio of 4.98x indicates a premium valuation, which may pose risks if revenue growth does not keep pace with market expectations.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Fine Organic Industries reveals a stable promoter holding of 75%, indicating strong management control. Foreign institutional investors (FIIs) held 4.57%, while domestic institutional investors (DIIs) accounted for 12.02%, showing moderate institutional interest. Public shareholding stood at 8.41%, reflecting a diverse ownership base among retail investors. The total number of shareholders declined to 97,992 as of September 2025, indicating a potential consolidation among investors. The consistent promoter stake and the presence of institutional investors may enhance investor confidence, although the declining number of shareholders could raise concerns about liquidity in the stock. Overall, the stability in shareholding suggests a resilient governance structure that supports long-term growth.
Outlook, Risks, and Final Insight
Fine Organic’s outlook hinges on its ability to navigate revenue fluctuations while maintaining profitability. Key strengths include a robust balance sheet, high liquidity, and strong operational efficiency as evidenced by the high ICR. However, risks remain, particularly the declining sales trajectory and increased cash conversion cycle, which could pressure liquidity and operational efficiency. Additionally, external factors such as changing regulatory environments and raw material price volatility could impact margins. To sustain growth, the company may need to enhance its working capital management and explore new markets or product lines. If Fine Organic successfully addresses these challenges, it could strengthen its competitive position in the specialty chemicals sector, but failure to adapt may hinder future performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 55.7 Cr. | 156 | 437/135 | 130 | 392 | 0.06 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 6,206 Cr. | 7,828 | 14,250/7,772 | 44.9 | 1,177 | 0.10 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 23.7 Cr. | 79.0 | 329/73.0 | 11.7 | 26.9 | 1.27 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 190 Cr. | 237 | 435/163 | 10.5 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,406.75 Cr | 1,375.13 | 54.47 | 334.84 | 0.45% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 919 | 760 | 597 | 547 | 540 | 488 | 547 | 550 | 596 | 517 | 607 | 588 | 597 |
| Expenses | 665 | 600 | 395 | 407 | 410 | 371 | 403 | 410 | 446 | 414 | 487 | 466 | 463 |
| Operating Profit | 254 | 159 | 202 | 140 | 130 | 117 | 144 | 139 | 150 | 103 | 120 | 123 | 134 |
| OPM % | 28% | 21% | 34% | 26% | 24% | 24% | 26% | 25% | 25% | 20% | 20% | 21% | 22% |
| Other Income | 19 | 15 | 13 | 14 | 17 | 17 | 22 | 24 | 22 | 25 | 26 | 47 | 21 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 |
| Depreciation | 12 | 12 | 13 | 12 | 14 | 15 | 15 | 12 | 13 | 13 | 15 | 12 | 13 |
| Profit before tax | 260 | 161 | 201 | 143 | 132 | 119 | 150 | 151 | 159 | 115 | 130 | 157 | 142 |
| Tax % | 22% | 34% | 26% | 30% | 22% | 21% | 24% | 25% | 26% | 28% | 25% | 26% | 24% |
| Net Profit | 203 | 106 | 149 | 100 | 103 | 94 | 115 | 113 | 117 | 83 | 97 | 117 | 109 |
| EPS in Rs | 66.09 | 34.65 | 48.74 | 32.54 | 33.71 | 30.73 | 37.36 | 36.94 | 38.30 | 26.97 | 31.68 | 38.19 | 35.40 |
Last Updated: January 2, 2026, 5:05 pm
Below is a detailed analysis of the quarterly data for Fine Organic Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 597.00 Cr.. The value appears strong and on an upward trend. It has increased from 588.00 Cr. (Jun 2025) to 597.00 Cr., marking an increase of 9.00 Cr..
- For Expenses, as of Sep 2025, the value is 463.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 466.00 Cr. (Jun 2025) to 463.00 Cr., marking a decrease of 3.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 134.00 Cr.. The value appears strong and on an upward trend. It has increased from 123.00 Cr. (Jun 2025) to 134.00 Cr., marking an increase of 11.00 Cr..
- For OPM %, as of Sep 2025, the value is 22.00%. The value appears strong and on an upward trend. It has increased from 21.00% (Jun 2025) to 22.00%, marking an increase of 1.00%.
- For Other Income, as of Sep 2025, the value is 21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 47.00 Cr. (Jun 2025) to 21.00 Cr., marking a decrease of 26.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.00 Cr. (Jun 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 13.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.00 Cr. (Jun 2025) to 13.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 142.00 Cr.. The value appears to be declining and may need further review. It has decreased from 157.00 Cr. (Jun 2025) to 142.00 Cr., marking a decrease of 15.00 Cr..
- For Tax %, as of Sep 2025, the value is 24.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Jun 2025) to 24.00%, marking a decrease of 2.00%.
- For Net Profit, as of Sep 2025, the value is 109.00 Cr.. The value appears to be declining and may need further review. It has decreased from 117.00 Cr. (Jun 2025) to 109.00 Cr., marking a decrease of 8.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 35.40. The value appears to be declining and may need further review. It has decreased from 38.19 (Jun 2025) to 35.40, marking a decrease of 2.79.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:45 am
| Metric | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 660 | 778 | 856 | 1,060 | 1,038 | 1,133 | 1,876 | 3,023 | 2,123 | 2,269 | 2,309 |
| Expenses | 514 | 633 | 697 | 827 | 803 | 935 | 1,513 | 2,194 | 1,591 | 1,757 | 1,830 |
| Operating Profit | 146 | 145 | 158 | 234 | 235 | 198 | 363 | 829 | 532 | 512 | 479 |
| OPM % | 22% | 19% | 19% | 22% | 23% | 17% | 19% | 27% | 25% | 23% | 21% |
| Other Income | 8 | 4 | 16 | 20 | 20 | 17 | 33 | 64 | 71 | 98 | 119 |
| Interest | 7 | 4 | 3 | 2 | 5 | 6 | 5 | 5 | 2 | 2 | 2 |
| Depreciation | 30 | 24 | 20 | 17 | 35 | 47 | 40 | 48 | 57 | 52 | 53 |
| Profit before tax | 117 | 121 | 151 | 234 | 216 | 162 | 352 | 841 | 544 | 555 | 544 |
| Tax % | 35% | 36% | 37% | 40% | 24% | 26% | 26% | 26% | 24% | 26% | |
| Net Profit | 76 | 78 | 95 | 136 | 165 | 120 | 260 | 618 | 412 | 410 | 405 |
| EPS in Rs | 157.74 | 161.22 | 31.09 | 44.43 | 53.74 | 39.24 | 84.67 | 201.60 | 134.34 | 133.89 | 132.24 |
| Dividend Payout % | 29% | 9% | 23% | 16% | 13% | 28% | 11% | 4% | 7% | 8% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 2.63% | 21.79% | 43.16% | 21.32% | -27.27% | 116.67% | 137.69% | -33.33% | -0.49% |
| Change in YoY Net Profit Growth (%) | 0.00% | 19.16% | 21.36% | -21.83% | -48.60% | 143.94% | 21.03% | -171.03% | 32.85% |
Fine Organic Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | 7% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 20% |
| 3 Years: | 17% |
| TTM: | -4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 13% |
| 3 Years: | -7% |
| 1 Year: | -9% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 28% |
| 3 Years: | 28% |
| Last Year: | 19% |
Last Updated: September 4, 2025, 9:35 pm
Balance Sheet
Last Updated: December 4, 2025, 12:51 am
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 249 | 323 | 380 | 485 | 604 | 716 | 944 | 1,526 | 1,906 | 2,280 | 2,462 |
| Borrowings | 102 | 40 | 54 | 128 | 125 | 89 | 59 | 29 | 4 | 3 | 16 |
| Other Liabilities | 63 | 76 | 81 | 74 | 108 | 127 | 219 | 237 | 182 | 213 | 167 |
| Total Liabilities | 419 | 445 | 530 | 702 | 852 | 948 | 1,236 | 1,807 | 2,108 | 2,511 | 2,660 |
| Fixed Assets | 125 | 97 | 88 | 78 | 217 | 196 | 229 | 214 | 268 | 363 | 373 |
| CWIP | 6 | 3 | 32 | 106 | 6 | 26 | 14 | 40 | 30 | 27 | 36 |
| Investments | 0 | 11 | 11 | 10 | 33 | 31 | 31 | 39 | 36 | 35 | 34 |
| Other Assets | 289 | 334 | 399 | 508 | 597 | 694 | 962 | 1,513 | 1,774 | 2,085 | 2,218 |
| Total Assets | 419 | 445 | 530 | 702 | 852 | 948 | 1,236 | 1,807 | 2,108 | 2,511 | 2,660 |
Below is a detailed analysis of the balance sheet data for Fine Organic Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 15.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,462.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,280.00 Cr. (Mar 2025) to 2,462.00 Cr., marking an increase of 182.00 Cr..
- For Borrowings, as of Sep 2025, the value is 16.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 3.00 Cr. (Mar 2025) to 16.00 Cr., marking an increase of 13.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 167.00 Cr.. The value appears to be improving (decreasing). It has decreased from 213.00 Cr. (Mar 2025) to 167.00 Cr., marking a decrease of 46.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,660.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,511.00 Cr. (Mar 2025) to 2,660.00 Cr., marking an increase of 149.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 373.00 Cr.. The value appears strong and on an upward trend. It has increased from 363.00 Cr. (Mar 2025) to 373.00 Cr., marking an increase of 10.00 Cr..
- For CWIP, as of Sep 2025, the value is 36.00 Cr.. The value appears strong and on an upward trend. It has increased from 27.00 Cr. (Mar 2025) to 36.00 Cr., marking an increase of 9.00 Cr..
- For Investments, as of Sep 2025, the value is 34.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35.00 Cr. (Mar 2025) to 34.00 Cr., marking a decrease of 1.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,218.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,085.00 Cr. (Mar 2025) to 2,218.00 Cr., marking an increase of 133.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,660.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,511.00 Cr. (Mar 2025) to 2,660.00 Cr., marking an increase of 149.00 Cr..
Notably, the Reserves (2,462.00 Cr.) exceed the Borrowings (16.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 44.00 | 105.00 | 104.00 | 106.00 | 110.00 | 109.00 | 304.00 | 800.00 | 528.00 | 509.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 49 | 52 | 62 | 54 | 47 | 52 | 59 | 42 | 54 | 53 |
| Inventory Days | 72 | 68 | 58 | 50 | 79 | 63 | 72 | 91 | 78 | 100 |
| Days Payable | 50 | 47 | 46 | 30 | 51 | 49 | 47 | 36 | 41 | 43 |
| Cash Conversion Cycle | 71 | 72 | 75 | 74 | 74 | 66 | 84 | 97 | 91 | 110 |
| Working Capital Days | 80 | 69 | 80 | 76 | 63 | 65 | 79 | 76 | 77 | 104 |
| ROCE % | 35% | 38% | 44% | 32% | 22% | 39% | 65% | 31% | 26% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Small Cap Fund | 785,023 | 0.47 | 323.13 | 752,764 | 2025-12-08 07:42:13 | 4.29% |
| SBI Small Cap Fund | 666,183 | 0.76 | 274.21 | 700,000 | 2025-12-06 00:21:08 | -4.83% |
| Axis Small Cap Fund | 633,550 | 0.98 | 260.78 | 713,350 | 2025-12-06 00:21:08 | -11.19% |
| Axis Midcap Fund | 307,724 | 0.4 | 126.67 | 307,724 | 2025-04-22 15:57:01 | 0% |
| Axis Flexi Cap Fund | 303,189 | 0.96 | 124.8 | 304,168 | 2025-12-07 10:03:29 | -0.32% |
| ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 170,399 | 1.09 | 70.14 | N/A | N/A | N/A |
| UTI Small Cap Fund | 93,777 | 0.81 | 38.6 | 46,684 | 2025-12-08 01:35:25 | 100.88% |
| ICICI Prudential Multicap Fund | 57,424 | 0.15 | 23.64 | 56,818 | 2026-01-25 00:03:40 | 1.07% |
| WhiteOak Capital Flexi Cap Fund | 38,114 | 0.22 | 15.69 | N/A | N/A | N/A |
| Mahindra Manulife Manufacturing Fund | 22,325 | 1.24 | 9.19 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 133.89 | 134.34 | 201.60 | 84.71 | 39.25 |
| Diluted EPS (Rs.) | 133.89 | 134.34 | 201.60 | 84.71 | 39.25 |
| Cash EPS (Rs.) | 151.21 | 153.52 | 217.80 | 98.06 | 54.93 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 748.61 | 626.57 | 502.69 | 312.85 | 238.57 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 748.61 | 626.57 | 502.69 | 312.85 | 238.57 |
| Revenue From Operations / Share (Rs.) | 740.10 | 692.42 | 986.00 | 611.96 | 369.61 |
| PBDIT / Share (Rs.) | 199.11 | 197.62 | 291.99 | 129.67 | 70.56 |
| PBIT / Share (Rs.) | 182.06 | 179.31 | 276.37 | 116.66 | 55.31 |
| PBT / Share (Rs.) | 181.34 | 178.33 | 274.88 | 114.99 | 53.31 |
| Net Profit / Share (Rs.) | 134.16 | 135.20 | 202.18 | 85.04 | 39.68 |
| NP After MI And SOA / Share (Rs.) | 133.89 | 134.34 | 201.60 | 84.67 | 39.24 |
| PBDIT Margin (%) | 26.90 | 28.54 | 29.61 | 21.18 | 19.09 |
| PBIT Margin (%) | 24.59 | 25.89 | 28.02 | 19.06 | 14.96 |
| PBT Margin (%) | 24.50 | 25.75 | 27.87 | 18.79 | 14.42 |
| Net Profit Margin (%) | 18.12 | 19.52 | 20.50 | 13.89 | 10.73 |
| NP After MI And SOA Margin (%) | 18.09 | 19.40 | 20.44 | 13.83 | 10.61 |
| Return on Networth / Equity (%) | 17.88 | 21.44 | 40.10 | 27.06 | 16.45 |
| Return on Capital Employeed (%) | 24.30 | 28.58 | 54.94 | 36.30 | 21.39 |
| Return On Assets (%) | 16.35 | 19.54 | 34.21 | 20.99 | 12.70 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.02 | 0.07 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.06 | 0.07 |
| Asset Turnover Ratio (%) | 0.98 | 1.08 | 2.01 | 1.71 | 1.24 |
| Current Ratio (X) | 8.46 | 9.13 | 5.37 | 3.53 | 4.01 |
| Quick Ratio (X) | 6.76 | 7.71 | 3.68 | 2.60 | 3.20 |
| Inventory Turnover Ratio (X) | 7.28 | 3.07 | 7.20 | 7.44 | 5.95 |
| Dividend Payout Ratio (NP) (%) | 7.46 | 6.69 | 4.46 | 12.99 | 7.64 |
| Dividend Payout Ratio (CP) (%) | 6.62 | 5.89 | 4.14 | 11.26 | 5.50 |
| Earning Retention Ratio (%) | 92.54 | 93.31 | 95.54 | 87.01 | 92.36 |
| Cash Earning Retention Ratio (%) | 93.38 | 94.11 | 95.86 | 88.74 | 94.50 |
| Interest Coverage Ratio (X) | 278.05 | 249.04 | 195.73 | 77.82 | 35.30 |
| Interest Coverage Ratio (Post Tax) (X) | 188.34 | 171.61 | 136.52 | 52.03 | 20.84 |
| Enterprise Value (Cr.) | 11296.88 | 11309.92 | 12708.88 | 12135.04 | 6792.44 |
| EV / Net Operating Revenue (X) | 4.98 | 5.33 | 4.20 | 6.47 | 5.99 |
| EV / EBITDA (X) | 18.50 | 18.67 | 14.20 | 30.52 | 31.40 |
| MarketCap / Net Operating Revenue (X) | 5.40 | 5.82 | 4.37 | 6.56 | 6.18 |
| Retention Ratios (%) | 92.53 | 93.30 | 95.53 | 87.00 | 92.35 |
| Price / BV (X) | 5.34 | 6.43 | 8.57 | 12.83 | 9.57 |
| Price / Net Operating Revenue (X) | 5.40 | 5.82 | 4.37 | 6.56 | 6.18 |
| EarningsYield | 0.03 | 0.03 | 0.04 | 0.02 | 0.01 |
After reviewing the key financial ratios for Fine Organic Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 133.89. This value is within the healthy range. It has decreased from 134.34 (Mar 24) to 133.89, marking a decrease of 0.45.
- For Diluted EPS (Rs.), as of Mar 25, the value is 133.89. This value is within the healthy range. It has decreased from 134.34 (Mar 24) to 133.89, marking a decrease of 0.45.
- For Cash EPS (Rs.), as of Mar 25, the value is 151.21. This value is within the healthy range. It has decreased from 153.52 (Mar 24) to 151.21, marking a decrease of 2.31.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 748.61. It has increased from 626.57 (Mar 24) to 748.61, marking an increase of 122.04.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 748.61. It has increased from 626.57 (Mar 24) to 748.61, marking an increase of 122.04.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 740.10. It has increased from 692.42 (Mar 24) to 740.10, marking an increase of 47.68.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 199.11. This value is within the healthy range. It has increased from 197.62 (Mar 24) to 199.11, marking an increase of 1.49.
- For PBIT / Share (Rs.), as of Mar 25, the value is 182.06. This value is within the healthy range. It has increased from 179.31 (Mar 24) to 182.06, marking an increase of 2.75.
- For PBT / Share (Rs.), as of Mar 25, the value is 181.34. This value is within the healthy range. It has increased from 178.33 (Mar 24) to 181.34, marking an increase of 3.01.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 134.16. This value is within the healthy range. It has decreased from 135.20 (Mar 24) to 134.16, marking a decrease of 1.04.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 133.89. This value is within the healthy range. It has decreased from 134.34 (Mar 24) to 133.89, marking a decrease of 0.45.
- For PBDIT Margin (%), as of Mar 25, the value is 26.90. This value is within the healthy range. It has decreased from 28.54 (Mar 24) to 26.90, marking a decrease of 1.64.
- For PBIT Margin (%), as of Mar 25, the value is 24.59. This value exceeds the healthy maximum of 20. It has decreased from 25.89 (Mar 24) to 24.59, marking a decrease of 1.30.
- For PBT Margin (%), as of Mar 25, the value is 24.50. This value is within the healthy range. It has decreased from 25.75 (Mar 24) to 24.50, marking a decrease of 1.25.
- For Net Profit Margin (%), as of Mar 25, the value is 18.12. This value exceeds the healthy maximum of 10. It has decreased from 19.52 (Mar 24) to 18.12, marking a decrease of 1.40.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 18.09. This value is within the healthy range. It has decreased from 19.40 (Mar 24) to 18.09, marking a decrease of 1.31.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.88. This value is within the healthy range. It has decreased from 21.44 (Mar 24) to 17.88, marking a decrease of 3.56.
- For Return on Capital Employeed (%), as of Mar 25, the value is 24.30. This value is within the healthy range. It has decreased from 28.58 (Mar 24) to 24.30, marking a decrease of 4.28.
- For Return On Assets (%), as of Mar 25, the value is 16.35. This value is within the healthy range. It has decreased from 19.54 (Mar 24) to 16.35, marking a decrease of 3.19.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.98. It has decreased from 1.08 (Mar 24) to 0.98, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 8.46. This value exceeds the healthy maximum of 3. It has decreased from 9.13 (Mar 24) to 8.46, marking a decrease of 0.67.
- For Quick Ratio (X), as of Mar 25, the value is 6.76. This value exceeds the healthy maximum of 2. It has decreased from 7.71 (Mar 24) to 6.76, marking a decrease of 0.95.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.28. This value is within the healthy range. It has increased from 3.07 (Mar 24) to 7.28, marking an increase of 4.21.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 7.46. This value is below the healthy minimum of 20. It has increased from 6.69 (Mar 24) to 7.46, marking an increase of 0.77.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.62. This value is below the healthy minimum of 20. It has increased from 5.89 (Mar 24) to 6.62, marking an increase of 0.73.
- For Earning Retention Ratio (%), as of Mar 25, the value is 92.54. This value exceeds the healthy maximum of 70. It has decreased from 93.31 (Mar 24) to 92.54, marking a decrease of 0.77.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.38. This value exceeds the healthy maximum of 70. It has decreased from 94.11 (Mar 24) to 93.38, marking a decrease of 0.73.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 278.05. This value is within the healthy range. It has increased from 249.04 (Mar 24) to 278.05, marking an increase of 29.01.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 188.34. This value is within the healthy range. It has increased from 171.61 (Mar 24) to 188.34, marking an increase of 16.73.
- For Enterprise Value (Cr.), as of Mar 25, the value is 11,296.88. It has decreased from 11,309.92 (Mar 24) to 11,296.88, marking a decrease of 13.04.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.98. This value exceeds the healthy maximum of 3. It has decreased from 5.33 (Mar 24) to 4.98, marking a decrease of 0.35.
- For EV / EBITDA (X), as of Mar 25, the value is 18.50. This value exceeds the healthy maximum of 15. It has decreased from 18.67 (Mar 24) to 18.50, marking a decrease of 0.17.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.40. This value exceeds the healthy maximum of 3. It has decreased from 5.82 (Mar 24) to 5.40, marking a decrease of 0.42.
- For Retention Ratios (%), as of Mar 25, the value is 92.53. This value exceeds the healthy maximum of 70. It has decreased from 93.30 (Mar 24) to 92.53, marking a decrease of 0.77.
- For Price / BV (X), as of Mar 25, the value is 5.34. This value exceeds the healthy maximum of 3. It has decreased from 6.43 (Mar 24) to 5.34, marking a decrease of 1.09.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.40. This value exceeds the healthy maximum of 3. It has decreased from 5.82 (Mar 24) to 5.40, marking a decrease of 0.42.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fine Organic Industries Ltd:
- Net Profit Margin: 18.12%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 24.3% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.88% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 188.34
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 6.76
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 33.8 (Industry average Stock P/E: 54.47)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 18.12%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Fine House, Anandji Street, Mumbai Maharashtra 400077 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mukesh Shah | Chairman & Wholetime Director |
| Mr. Jayen Shah | Managing Director |
| Mr. Tushar Shah | WholeTime Director & CEO |
| Mr. Bimal Shah | Executive Director |
| Mr. Nikhil Kamat | Executive Director |
| Mr. Kaushik Shah | Independent Director |
| Mr. Mahesh Sarda | Independent Director |
| Mr. Thiruvengadam Parthasarathi | Independent Director |
| Ms. Pratima Umarji | Independent Director |
| Mr. Prakash Apte | Independent Director |
| Ms. Rashi Mehta | Independent Director |
FAQ
What is the intrinsic value of Fine Organic Industries Ltd?
Fine Organic Industries Ltd's intrinsic value (as of 06 February 2026) is ₹4669.42 which is 5.86% higher the current market price of ₹4,411.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹13,524 Cr. market cap, FY2025-2026 high/low of ₹5,494/3,355, reserves of ₹2,462 Cr, and liabilities of ₹2,660 Cr.
What is the Market Cap of Fine Organic Industries Ltd?
The Market Cap of Fine Organic Industries Ltd is 13,524 Cr..
What is the current Stock Price of Fine Organic Industries Ltd as on 06 February 2026?
The current stock price of Fine Organic Industries Ltd as on 06 February 2026 is ₹4,411.
What is the High / Low of Fine Organic Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Fine Organic Industries Ltd stocks is ₹5,494/3,355.
What is the Stock P/E of Fine Organic Industries Ltd?
The Stock P/E of Fine Organic Industries Ltd is 33.8.
What is the Book Value of Fine Organic Industries Ltd?
The Book Value of Fine Organic Industries Ltd is 808.
What is the Dividend Yield of Fine Organic Industries Ltd?
The Dividend Yield of Fine Organic Industries Ltd is 0.25 %.
What is the ROCE of Fine Organic Industries Ltd?
The ROCE of Fine Organic Industries Ltd is 26.4 %.
What is the ROE of Fine Organic Industries Ltd?
The ROE of Fine Organic Industries Ltd is 19.5 %.
What is the Face Value of Fine Organic Industries Ltd?
The Face Value of Fine Organic Industries Ltd is 5.00.